Pulmonary inflammation and viral replication define distinct clinical outcomes in fatal cases of COVID-19.

MLA

de Sá, Keyla S. G., et al. “Pulmonary Inflammation and Viral Replication Define Distinct Clinical Outcomes in Fatal Cases of COVID-19.” PLoS Pathogens, vol. 20, no. 6, June 2024, p. e1012222. EBSCOhost, https://doi.org/10.1371/journal.ppat.1012222.

APA

de Sá, K. S. G., Amaral, L. A., Rodrigues, T. S., Caetano, C. C. S., Becerra, A., Batah, S. S., Lopes, F. T., de Oliveira, I. M., Lopes, L. S., Almeida, L., Mota, C. M., Oliveira, S., Wada, D. T., Koenigkam-Santos, M., Martins, R. B., Rosales, R. R. C., Arruda, E., Fabro, A. T., & Zamboni, D. S. (2024). Pulmonary inflammation and viral replication define distinct clinical outcomes in fatal cases of COVID-19. PLoS Pathogens, 20(6), e1012222. https://doi.org/10.1371/journal.ppat.1012222

Chicago

de Sá, Keyla S G, Luana A Amaral, Tamara S Rodrigues, Camila C S Caetano, Amanda Becerra, Sabrina S Batah, Felipe T Lopes, et al. 2024. “Pulmonary Inflammation and Viral Replication Define Distinct Clinical Outcomes in Fatal Cases of COVID-19.” PLoS Pathogens 20 (6): e1012222. doi:10.1371/journal.ppat.1012222.